Hansa Biopharma presented new data on imlifidase at the European Society for Organ Transplantation (ESOT) Congress ...Middle East

LUND, Sweden, Sept. 1, 2021 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), the pioneer in enzyme technology for rare immunological conditions, today announced two abstracts presented at the European Society for Organ Transplantation (ESOT) Congress, August 29-September...

Hence then, the article about hansa biopharma presented new data on imlifidase at the european society for organ transplantation esot congress was published today ( Wednesday 01/09/2021 - 09:45 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Hansa Biopharma presented new data on imlifidase at the European Society for Organ Transplantation (ESOT) Congress )

Also on site :

• China's First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent's TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval
• Prominent Canadian Musician Says Gig Was Cancelled After Google AI Overview Wrongly Branded Him Sex Pest
• Goldman Sachs expects layoffs to keep rising—and says investors are punishing the stocks of companies that slash staff